1. NCMP-05. RITUXIMAB AS INITIAL THERAPY FOR THE REVERSAL OF MYASTHENIA GRAVIS NEUROTOXICITY CAUSED BY IPILIMUMAB/NIVOLUMAB. (5th November 2018) Authors: Verma, Neha; Jaffer, Muhammed; Peguero, Edwin; Mokhtari, Sepideh Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗